Certified by Founder Lodge
Beacon Therapeutics
United States - Alachua, Florida
START UP
1 Disclosed Funding Rounds $170,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Beacon Therapeutics is an ophthalmic gene therapy company founded in 2023 to save and restore the vision of patients with a range of prevalent and rare retinal diseases that result in blindne
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 10 ,2024 | Series B | $170,000,000 |
Oxford Science Enterprises
Advent Life Sciences
Forbion
Syncona Limited
University of Oxford
TCGX
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Adronite | $5,000,000 | (Feb 20, 2026)
SPRX | $31,000,000 | (Feb 20, 2026)
Vizzia | $35,300,400 | (Feb 20, 2026)
Altesa BioSciences, Inc. | $75,000,000 | (Feb 20, 2026)
NuCube Energy | $13,000,000 | (Feb 20, 2026)
